ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,881.63
      0.00%
      US Tech 100
      20,680.00
      1.13%
      Dow Jones
      42,544.22
      0.00%
      Brent Oil
      75.66
      2.44%
      Bitcoin
      96,356.46
      2.08%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Lyra Therapeutics Inc (LYRA) Quote

      Lyra Therapeutics Inc

      Lyra Therapeutics Inc (LYRA)

      NASDAQ
      0.2064
      -0.0136
      (-6.18%)
      Closed December 31 4:00PM
      Delayed by 15 minutes
      0.2088
      0.0024
      ( 1.16% )
      Pre Market: 8:42AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.2088
      Bid
      0.2028
      Ask
      0.21
      Volume
      104,093
      0.00 Day's Range 0.00
      0.1625 52 Week Range 6.79
      Market Cap
      13.668M
      Previous Close
      0.2064
      Open
      -
      Last Trade
      80
      @
      0.2089
      Last Trade Time
      08:42:14
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,964,356
      Shares Outstanding
      65,457,648
      Dividend Yield
      -
      PE Ratio
      -0.22
      Earnings Per Share (EPS)
      -0.96
      Revenue
      1.56M
      Net Profit
      -62.68M

      About Lyra Therapeutics Inc

      Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      lyratherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was $0.21. Over the last year, Lyra Therapeutics shares have traded in a share price range of $ 0.1625 to $ 6.79.

      Lyra Therapeutics currently has 65,457,648 shares outstanding. The market capitalization of Lyra Therapeutics is $13.51 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.22.

      Ask ADVFN Intelligence (AI)

      LYRA Latest News

      More News

      Form 8-K - Current report

      December 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 11 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.033819.31428571430.1750.2450.172830048780.20712057CS
      4-0.0023-1.089531027950.21110.2450.163517343910.19576821CS
      12-0.0143-6.409681757060.22310.29980.162519643560.21159696CS
      26-0.0902-30.16722408030.2990.3440.162513841680.24014065CS
      52-4.9612-95.96131528055.176.790.162516888700.70109523CS
      156-4.2012-95.26530612244.418.180.16256567681.21112533CS
      260-20.7912-99.005714285721220.16254563661.99422521CS

      LYRA - Frequently Asked Questions (FAQ)

      What is the current Lyra Therapeutics share price?
      The current share price of Lyra Therapeutics is $ 0.2088
      How many Lyra Therapeutics shares are in issue?
      Lyra Therapeutics has 65,457,648 shares in issue
      What is the market cap of Lyra Therapeutics?
      The market capitalisation of Lyra Therapeutics is USD 13.51M
      What is the 1 year trading range for Lyra Therapeutics share price?
      Lyra Therapeutics has traded in the range of $ 0.1625 to $ 6.79 during the past year
      What is the PE ratio of Lyra Therapeutics?
      The price to earnings ratio of Lyra Therapeutics is -0.22
      What is the cash to sales ratio of Lyra Therapeutics?
      The cash to sales ratio of Lyra Therapeutics is 8.82
      What is the reporting currency for Lyra Therapeutics?
      Lyra Therapeutics reports financial results in USD
      What is the latest annual turnover for Lyra Therapeutics?
      The latest annual turnover of Lyra Therapeutics is USD 1.56M
      What is the latest annual profit for Lyra Therapeutics?
      The latest annual profit of Lyra Therapeutics is USD -62.68M
      What is the registered address of Lyra Therapeutics?
      The registered address for Lyra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Lyra Therapeutics website address?
      The website address for Lyra Therapeutics is lyratherapeutics.com
      Which industry sector does Lyra Therapeutics operate in?
      Lyra Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RAINRain Enhancement Technologies Holdco Inc
       11.39
      (841.32%)
      		260
      TOIIWOncology Institute Inc
      $ 0.0123
      (136.54%)
      		4.47k
      CTCXCarmell Corporation
      $ 0.6461
      (131.49%)
      		43.28M
      REVBRevelation Biosciences Inc
      $ 1.0099
      (119.07%)
      		45.35M
      CGBSCrown LNG Holdings Ltd
      $ 0.8742
      (118.50%)
      		73.64M
      NMRANeumora Therapeutics Inc
      $ 1.7606
      (-83.39%)
      		3.57M
      BDMDBaird Medical Investment Holdings Ltd
      $ 4.71
      (-38.03%)
      		459.06k
      SIDUSidus Space Inc
      $ 3.51
      (-28.37%)
      		3.09M
      MARXMars Acquisition Corporation
      $ 7.26
      (-22.35%)
      		46.74k
      BFINBankFinancial Corporation
      $ 10.01
      (-21.15%)
      		9
      CGBSCrown LNG Holdings Ltd
      $ 0.8742
      (118.50%)
      		73.64M
      CMCTCreative Media and Community Trust Corporation
      $ 0.3353
      (49.02%)
      		59.01M
      REVBRevelation Biosciences Inc
      $ 1.0099
      (119.07%)
      		45.35M
      CTCXCarmell Corporation
      $ 0.6461
      (131.49%)
      		43.28M
      SVMHSRIVARU Holding Ltd
      $ 0.0469
      (11.40%)
      		41.56M

      LYRA Discussion

      View Posts
      glenn1919 glenn1919 2 days ago
      lyra.................................https://stockcharts.com/h-sc/ui?s=lyra&p=W&b=5&g=0&id=p86431144783

















      lostintheshuffle.......................8
      👍️0
      tw0122 tw0122 2 days ago
      .24
      👍️0
      tw0122 tw0122 2 days ago
      .24
      👍️0
      Dennis14 Dennis14 5 months ago
      Earnings out.
      👍️0
      Dennis14 Dennis14 5 months ago
      Big buys after hours 86000 buy and (3)50000 buys
      👍️0
      Dennis14 Dennis14 5 months ago
      It now says 13th after hours. We will see
      👍️0
      Dennis14 Dennis14 5 months ago
      Earnings supposed to be on the 12th Aug.
      👍️0
      Dennis14 Dennis14 5 months ago
      I just read. Earnings coming out next week or the week after.
      👍️0
      Dennis14 Dennis14 5 months ago
      Earnings coming out any day now.
      👍️0
      BigBadWolf BigBadWolf 7 months ago
      DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
      https://lyratherapeutics.com/
      👍️0
      SantaZar SantaZar 7 months ago
      Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

      Find Winners Early:



      Z
      👍️0
      Termite7 Termite7 7 months ago
      Who? .....How high for LYRA? .......Thanks!!!
      👍️0
      SantaZar SantaZar 7 months ago
      Nice list.........$LYRA is due.......according to #DDAmanda.

      Z
      👍️0
      Termite7 Termite7 7 months ago
      Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change
      👍️0
      SantaZar SantaZar 7 months ago
      $LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

      Z
      👍️ 1
      INV4 INV4 7 months ago
      LYRA Institutional Holdings
      Ownership Summary

      Institutional Ownership • 74.73%
      Total Shares Outstanding (millions) • 61
      Total Value of Holdings (millions) • $16

      Active Positions • Holders • Shares
      Increased Positions • 54 • 9,224,767
      Decreased Positions • 19 • 6,026,566
      Held Positions • 11 • 30,304,888

      Institutional Holders: 84
      Total Shares Held: 45,556,221

      $BLEG

      LYRA Analyst Research
      Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
      LYRA Earnings Consensus

      CONSENSUS
      Buy
      Based on 6 analysts offering recommendations for 'LYRA'.

      Analyst Price Targets
      CONSENSUS
      $0.95

      Based on analysts offering 12 month price targets for LYRA in the last 3 months.
      The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

      https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

      $LYRA
      👍️0
      SantaZar SantaZar 7 months ago
      $LYRA Bounce anytime now...............

      Z
      👍️ 1
      INV4 INV4 7 months ago
      Let's see when it bounces 😀

      $LYRA
      👍️0
      glenn1919 glenn1919 8 months ago
      LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783
      👍️0
      SantaZar SantaZar 8 months ago
      Yes. Expecting a nice $LYRA Bounce..............

      Z
      👍️0
      Dennis14 Dennis14 8 months ago
      Relative Strength Index is at 12 this is way over sold.
      👍️0
      SantaZar SantaZar 8 months ago
      $LYRA Book Value: $1.28 ....currently at .43 ...

      Z
      👍️0
      Dennis14 Dennis14 8 months ago
      Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.
      👍️0
      axelvento axelvento 8 months ago
      game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint
      👍️0
      Monksdream Monksdream 8 months ago
      LYRA under $10

      👍️0
      Monksdream Monksdream 9 months ago
      LYRA under $10
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...NOT HOLDING INTO ER
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...LETS SEE 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...EXPLODING!!!!!
      👍️0
      Monksdream Monksdream 10 months ago
      LYRA 10Q due March 14
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...BEAUTIFUL BREAK OUT
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA....BIO BEAST!
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...MOVES ON AIR!!!
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...HERE WE GO
      👍️0
      Monksdream Monksdream 10 months ago
      LYRA 10Q due March 7
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA..WHAT A BEAUTY...NOBODY TALKING!!!
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      LYRA...NEXT BIO BEAST READY TO BEAST
      👍️0
      Monksdream Monksdream 1 year ago
      LYRA No 3 on the Barchart Top 10
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0

      Your Recent History

      NASDAQ
      LYRA
      Lyra Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads